Showing results (271-280 of 324) with videos related to

Sort By:
Pageof 33
Current Medicinal Chemistry|June 9, 2011
Progress in the preclinical discovery and clinical development of class I and dual class I/IV phosphoinositide 3-kinase (PI3K) inhibitorsS J Shuttleworth, F A Silva, A R L Cecil, et al.
European Journal of Cancer (Oxford, England : 1990)|August 17, 1999
Temozolomide in adult patients with advanced soft tissue sarcoma: a phase II study of the EORTC Soft Tissue and Bone Sarcoma GroupP J Woll, I Judson, S M Lee, et al.
Clinical Sarcoma Research|May 23, 2018
Aggressive fibromatosis response to tamoxifen: lack of correlation between MRI and symptomatic responseM Libertini, I Mitra, W T A van der Graaf, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 12, 2012
Chemotherapy treatment patterns and clinical outcomes in patients with metastatic soft tissue sarcoma. The SArcoma treatment and Burden of Illness in North America and Europe (SABINE) studyM Leahy, X Garcia Del Muro, P Reichardt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 1, 1997
Phase I and pharmacokinetic study of tirapazamine (SR 4233) administered every three weeksS Senan, R Rampling, M A Graham, et al.
Cancer Research|August 1, 1997
Preclinical evaluation of the fluorinated 2-nitroimidazole N-(2-hydroxy-3,3,3-trifluoropropyl)-2-(2-nitro-1-imidazolyl) acetamide (SR-4554) as a probe for the measurement of tumor hypoxiaE O Aboagye, R J Maxwell, A B Kelson, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Pharmacokinetics of the hypoxic cell cytotoxic agent tirapazamine and its major bioreductive metabolites in mice and humans: retrospective analysis of a pharmacokinetically guided dose-escalation strategy in a phase I trialM A Graham, S Senan, H Robin, et al.
The British Journal of Radiology|October 1, 1986
A comparative study of Ro 03-8799: racemic mixture and enantiomersH F Newman, E P Dunphy, N M Bleehen, et al.
Veterinary Parasitology|August 15, 2000
Selamectin: a novel broad-spectrum endectocide for dogs and catsB F Bishop, C I Bruce, N A Evans, et al.
British Journal of Cancer|October 1, 1985
Establishment and characterisation of cell lines from patients with lung cancer (predominantly small cell carcinoma)H Baillie-Johnson, P R Twentyman, N E Fox, et al.
Pageof 33